Fig. 1From: Activity of anthracycline- and ifosfamide-based chemotherapy in a series of patients affected by advanced myxofibrosarcomaSurvival functions for patients treated with front line anthracycline + ifosfamide chemotherapy (13 patients). a PFS (median 4 months). b OS (median 12 months)Back to article page